Last reviewed · How we verify
Docetaxel: increase of the dose — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Docetaxel: increase of the dose (Docetaxel: increase of the dose) — Centre Oscar Lambret.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Docetaxel: increase of the dose TARGET | Docetaxel: increase of the dose | Centre Oscar Lambret | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Docetaxel: increase of the dose CI watch — RSS
- Docetaxel: increase of the dose CI watch — Atom
- Docetaxel: increase of the dose CI watch — JSON
- Docetaxel: increase of the dose alone — RSS
Cite this brief
Drug Landscape (2026). Docetaxel: increase of the dose — Competitive Intelligence Brief. https://druglandscape.com/ci/docetaxel-increase-of-the-dose. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab